Home › Grants › United States › HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clin
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain.
Grant (non-repayable) Open now
- Funder
- National Institutes of Health
Funder profile and all of its programs - Amount
- Up to $350,000 per award (published on Grants.gov).
- Where
- United States (federal)
- Eligibility
- Open to businesses, self-employed people, nonprofits, colleges, universities, schools or research institutions and state, provincial, local or tribal governments. No cost sharing is required.
- Sectors
- Education and training, Health and life sciences, Nonprofits and charities, Research and science
- Deadline
- Closes 15 January 2027
- Source
- Grants.gov XML extract (RFA-NS-25-023)
- Last checked
- 2 November 2026
- Funder contacts
- Public organizational contacts on file Unlock full profile / Sign up
From official open data: listed in the official Grants.gov extract on 2026-11-02. The summary is from the official listing; the eligibility line is our plain-language reading of its eligibility codes. Confirm details on the official page.
Related grant lists
Education and training Health and life sciences Nonprofits and charities Governments and public bodies Schools, colleges and research institutions Nonprofits and charities United States United States (national) Federal agency $100,000 to $500,000 January 2027
Full eligibility results and funder contacts come with Pro and Lifetime, coming soon.
Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.